Search for: "Anda Inc"
Results 1 - 20
of 959
Sorted by Relevance
|
Sort by Date
29 Jan 2018, 12:51 pm
FDA-approved abbreviated new drug applications (ANDAs), one ANDA that FDA tentatively approved and three ANDAs that are pending FDA approval. [read post]
8 Apr 2014, 9:59 pm
Actavis, Inc. and Endo Pharmaceuticals Inc. v. [read post]
27 Dec 2022, 7:01 pm
Sandoz Inc. [read post]
18 Feb 2023, 8:41 pm
Jenna Deneault of Groombridge Wu will moderate a panel consisting of Jill Schmidt of Genentech, Inc.; Laura Lydigsen of Crowell & Moring LLP; Hassen Sayeed of O'Melveny & Myers LLP; and Josephine Young of Groombridge Wu. [read post]
29 Nov 2020, 9:59 pm
Hospira, Inc. [read post]
19 Apr 2010, 5:23 am
" Millennium Pharmaceuticals Inc. et al v. [read post]
26 Sep 2013, 9:33 pm
Teva Pharmaceuticals USA, Inc. [read post]
8 May 2017, 8:27 pm
Noonan -- The Federal Circuit's decision on Friday, in Braintree Laboratories, Inc. v. [read post]
3 Oct 2014, 9:55 pm
Paul Simboli of Depomed, Inc. will moderate a panel including Patty McDermott of the U.S. [read post]
30 Nov 2015, 7:12 am
" Jazz Pharmaceuticals, Inc. v. [read post]
10 Oct 2007, 8:29 pm
However, rather than filing a new ANDA itself, Apotex entered into an informal agreement with Nu-Pharm, Inc. [read post]
10 Nov 2020, 2:01 am
Mylan Pharmaceuticals Inc. [read post]
20 Aug 2019, 9:59 pm
Actavis Laboratories FL, Inc. [read post]
6 Apr 2009, 12:01 am
" PDL Biopharma, Inc. v. [read post]
20 Feb 2013, 7:37 am
Teva Pharmaceuticals USA Inc., et. al., 1-10-cv-00805 (DED February 11, 2013, Order) (Burke, M.J.). [read post]
30 Sep 2010, 8:19 am
Sandoz, Inc. et al., 1-08-cv-03710 (NYSD September 28, 2010, Memorandum Opinion & Order) (Gardephe, J.) [read post]
11 Jun 2023, 8:17 pm
Teva Pharmaceuticals USA, Inc. [read post]
3 Feb 2010, 9:39 pm
In Pfizer, Inc. v. [read post]
2 Apr 2015, 9:59 pm
The first filer, Mylan Pharmaceuticals, Inc. [read post]
18 Jul 2017, 9:58 pm
Noonan -- In multiple ANDA litigations against multiple defendants, Millennium Pharmaceuticals, Inc. had several of its asserted claims held invalid for obviousness at the district court. [read post]